Mutations in the TERT promoter are observed at high frequencies in tumors characterized by lower proliferative potential, including melanoma and HCC, but are infrequent or virtually absent in highly proliferative cancers, such as breast and testicular cancer [38, 113, 119, 122]. Here, TERT is linked to hepatocellular carcinoma.